Vaccinated and naïve mice (n = 5) were intranasally challenged with RSV A2 (5×105 PFU) at 3 weeks after a single dose. (A) Body weight changes after RSV infection. (B) Airway hyper-responsiveness to methacholine. PenH (enhanced pause) was measured by a whole body plethysmograph in live mice at day 4 post RSV challenge, with increasing concentrations of inhaled methacholine (0–100 mg/ml). (C) Lung RSV titers day 5 post challenge. The viral titers were confirmed in duplicate experiments and the dotted line represents the detection limit. PBS: unimmunized mice. PBS+RSV: unimmunized mice with RSV infection. The groups of IM, IM+MPL, MN, and MN+MPL are the same as described in Fig 1. Results are presented as mean ± SEM. Statistical significances...
<p>Bronchoconstrictive responses to increasing doses of nebulized methacholine (MCH) in: (<b>A</b>) ...
<p>On 1, 3, 5, and 7 dpi pups received 16 ng/g of i.n. rIFNγ or diluent only. (A) Daily weight chang...
<p>Groups of BALB/c mice were vaccinated with nanoparticle diluted in PBS to yield 50 µg of designed...
<p>(A) WT and dblGATA-1 mice vaccinated with FI-RSV were assessed daily for airway obstruction and w...
<p>(A) FI-mock- and FI-RSV-vaccinated mice were monitored daily for airway obstruction using a whole...
(A) Schematic representation of mouse immunization and challenge schedule. BALB/c mice (N = 6 per gr...
<p>Mice were i.m. vaccinated with formalin inactivated RSV A2, rested for at four weeks and i.n chal...
<p>At 12 weeks post-boost immunization, immune and PBS mock control mice (n = 5 per group) were i.n....
<p>Immunized mice were vaccinated intranasally (i.n.) twice at day 0 and day 28 with NE-RSV (10<sup>...
<p>Balb/c mice were immunized according to <a href="http://www.plosone.org/article/info:doi/10.1371/...
<p>BALB/c mice were immunized IN with RSV-virosomal vaccine formulations (5 µg of protein) or HNE. C...
<p>Mice (N = 7 per group) were immunized at days 0 and 14 with the indicated vaccines and challenged...
<p>BALB/c mice were administered twice at 2 weeks interval i.n. (A) or s.c (B) 10 µg N SRS and 5 µg ...
BACKGROUND: To characterise the acute physiological and inflammatory changes induced by low-dose RSV...
<p>Lung viral titers were determined from mice immunized with V1 or V5 VLPs and from FI-RSV immunize...
<p>Bronchoconstrictive responses to increasing doses of nebulized methacholine (MCH) in: (<b>A</b>) ...
<p>On 1, 3, 5, and 7 dpi pups received 16 ng/g of i.n. rIFNγ or diluent only. (A) Daily weight chang...
<p>Groups of BALB/c mice were vaccinated with nanoparticle diluted in PBS to yield 50 µg of designed...
<p>(A) WT and dblGATA-1 mice vaccinated with FI-RSV were assessed daily for airway obstruction and w...
<p>(A) FI-mock- and FI-RSV-vaccinated mice were monitored daily for airway obstruction using a whole...
(A) Schematic representation of mouse immunization and challenge schedule. BALB/c mice (N = 6 per gr...
<p>Mice were i.m. vaccinated with formalin inactivated RSV A2, rested for at four weeks and i.n chal...
<p>At 12 weeks post-boost immunization, immune and PBS mock control mice (n = 5 per group) were i.n....
<p>Immunized mice were vaccinated intranasally (i.n.) twice at day 0 and day 28 with NE-RSV (10<sup>...
<p>Balb/c mice were immunized according to <a href="http://www.plosone.org/article/info:doi/10.1371/...
<p>BALB/c mice were immunized IN with RSV-virosomal vaccine formulations (5 µg of protein) or HNE. C...
<p>Mice (N = 7 per group) were immunized at days 0 and 14 with the indicated vaccines and challenged...
<p>BALB/c mice were administered twice at 2 weeks interval i.n. (A) or s.c (B) 10 µg N SRS and 5 µg ...
BACKGROUND: To characterise the acute physiological and inflammatory changes induced by low-dose RSV...
<p>Lung viral titers were determined from mice immunized with V1 or V5 VLPs and from FI-RSV immunize...
<p>Bronchoconstrictive responses to increasing doses of nebulized methacholine (MCH) in: (<b>A</b>) ...
<p>On 1, 3, 5, and 7 dpi pups received 16 ng/g of i.n. rIFNγ or diluent only. (A) Daily weight chang...
<p>Groups of BALB/c mice were vaccinated with nanoparticle diluted in PBS to yield 50 µg of designed...